These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 27534738

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension.
    Jäättelä A, Baandrup S, Houtzagers J, Westergren G.
    J Clin Pharmacol; 1990 Feb; 30(S2):S66-71. PubMed ID: 2179283
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G, Berger J, Olsson G, Menzel T.
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [Abstract] [Full Text] [Related]

  • 6. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL, Clissold SP.
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P, Moore G, Wieselgren I, Olofsson B, Bergstrand R.
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects.
    Wieselgren I, Lundborg P, Sandberg A, Olofsson B, Bergstrand R.
    J Clin Pharmacol; 1990 Feb; 30(S2):S28-32. PubMed ID: 2312776
    [Abstract] [Full Text] [Related]

  • 12. Bisoprolol in the treatment of hypertension in the elderly.
    Broncel M, Chojnowska-Jezierska J, Adamska-Dyniewska H.
    J Hum Hypertens; 1998 Sep; 12(9):643-4. PubMed ID: 9783498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM, Rabot D, Herrero G.
    J Cardiovasc Pharmacol; 1990 Sep; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [Abstract] [Full Text] [Related]

  • 15. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
    Metelitsa VI, Duda SG, Gorbunov VM, Buchner-Moll D, Deev AD, Vygodin VA, Filatova NP, Chel'dieva EIa, Shastun RS, Simonov DV.
    Eksp Klin Farmakol; 1995 Sep; 58(2):32-4. PubMed ID: 7773086
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B, Hosie J.
    Blood Press Suppl; 1993 Sep; 1():22-9. PubMed ID: 8173687
    [Abstract] [Full Text] [Related]

  • 17. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B, Jonkman J, Zuiderwijk P, Sollie F.
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [Abstract] [Full Text] [Related]

  • 18. Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
    Dimenäs E, Ostergren J, Lindvall K, Dahlöf C, Westergren G, de Faire U.
    J Clin Pharmacol; 1990 Feb; 30(S2):S82-90. PubMed ID: 2179286
    [Abstract] [Full Text] [Related]

  • 19. Age dependence of therapy result and risk in the treatment of arterial hypertension?
    Höffler D, Morgenstern HO.
    J Cardiovasc Pharmacol; 1990 Feb; 16 Suppl 5():S184-8. PubMed ID: 11527125
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y, Neutel JM, Davidai G, Koval S.
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.